Barbell Insights

Qualitative research software for people tracking markets, companies, and operators.

Barbell turns longform podcast coverage into searchable entity timelines, alerts, and research context so you can find what matters without replaying every episode.

Company

About
Privacy
Terms
Support

Contact

support@barbellinsights.com

Barbell Insights is research software, not investment advice.

Barbell

HomeSearch

Tickers & PeopleSourcesPublic Episodes

BARBELLINSIGHTS

Barbell Insights

Qualitative research software for people tracking markets, companies, and operators.

Barbell turns longform podcast coverage into searchable entity timelines, alerts, and research context so you can find what matters without replaying every episode.

Company

About
Privacy
Terms
Support

Contact

support@barbellinsights.com

Barbell Insights is research software, not investment advice.

E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more – All-In with Chamath, Jason, Sacks & Friedberg

E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more

Episode publishedJune 13, 2021Podcast: All-In with Chamath, Jason, Sa...All-In with Chamath, Jason, Sacks & Friedberg↗

Explore this episode

Prepare a transcript and summary so you can explore the episode and ask questions about what was said.

Search across episodes